CRISPR Therapeutics (NASDAQ:CRSP) is one of the best stocks for 20 years. On February 12, CRISPR Therapeutics announced its ...

Rice University researchers have developed a CRISPR-based gene activation strategy that boosts mitochondrial production in damaged heart cells, improving cardiac function after heart attacks in both ...

After a heart attack, the heart struggles to recoup and maintain energy. One-third of patients develop heart failure as a ...

The FDA has liberated the second of two Intellia Therapeutics clinical trials that were put on hold last October following a report of serious liver toxicity that later led to death.

Now, it’s worth noting Stock Advisor’s total average return is 892 % — a market-crushing outperformance compared to 194% for ...

After a heart attack, the heart struggles to recoup and maintain energy. One third of patients develop heart failure as a ...

Add Yahoo as a preferred source to see more of our stories on Google. Stanford researchers have developed CRISPR-GPT, an AI-powered copilot that guides gene-editing experiments. (CREDIT: Shutterstock) ...

One year after receiving CRISPR gene editing therapy at CHOP, a Delaware County baby is thriving, and doctors want to expand treatment to others.

The FDA last October paused Intellia Therapeutics’ late-stage CRISPR studies after detecting life-threatening enzyme ...

In the wake of the germline editing controversy, when Chinese scientist He Jianku illegally edited the embryos of human twins, the ethics of CRISPR therapy have had global attention. Many countries ...

Saudi Arabia's cell and gene therapy market is driven by rising demand for innovative treatments targeting chronic and ...